FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200417908> ?p ?o ?g. }

• W4200417908 abstract "Background. Although immunotherapy has led to exceptional and durable clinical response, the majority of patients respond poorly to the current immunotherapies. Growing evidence has linked some of the poor responsiveness to the gut microbiota, and the modulation of gut microbiome composition is becoming a promising new strategy to enhance immune checkpoint inhibitor (ICI) treatment outcome. Mouse tumor modelling under germ-free (GF) conditions combined with introduction of defined bacterial strains could be a useful approach to investigate the impact of microbiota on ICI efficacy, as well as understanding the underlying mechanisms. We previously demonstrated that GF mice exhibited a significantly poor response to anti-PD-1 therapy when compared to the specific pathogen free (SPF) mice in a subcutaneous MC38 colorectal cancer model, which is consistent with other reports. Methods. Introduction of a single strain of Bacillus in the GF-environment was assessed for its impact on the anti-mouse PD-1 monoclonal antibody (mAb) therapy in GF-mice and SPF mice, both for efficacy and pharmacodynamics tumor infiltrating lymphocytes (TILs) profiling. C57BL/6 mice were inoculated subcutaneously with MC38 tumor cells and when the tumors were reached 80-120mm3, the mice were randomized for isotype or anti-PD-1 mAb treatment. Fecal sample 16S rRNA analysis (NGS) was used to confirm the gut bacteria status. Results. The MC38 tumor in GF mice has significantly fast baseline growth kinetics, even with the introduction of Bacillus under GF conditions compared to SPF mice, suggesting tumor immunity was not enhanced by Bacillus. Despite the introduction of Bacillus, GF mice also showed reduced response to anti-PD-1 treatment when compared to the SPF mice as previously reported, further confirming that introduction of Bacillus had minimal effects on the efficacy of anti-PD-1 therapy. Moreover, the SPF mice and GF mice with Bacillus exhibited distinct profiles of TILs, consistent with distinct efficacies as observed. GF free mice showed a lower frequency of CD45+ TILs in comparison to SPF mice. In addition, GF mice exhibited lower frequency of CD8+ TILs and TIL- NKT when compared to the SPF mice, both of which are consistent with the stronger efficacy seen in SPF mice. Meanwhile, GF mice also exhibited higher granulocytic myeloid derived suppressor cells (gMDSC) and lower M1/M2 ratio, both of which imply a more suppressive tumor microenvironment in GF mice. Fecal sample analysis using 16S rRNA analysis confirmed a single strain of Bacillus was indeed introduced into the guts of all the GF mice. Conclusions. The GF conditions provide a useful environment for the investigation of specific microbiota strains on the impact on ICI treatment outcome. In summary, the introduction of Bacillus in GF mice did not impact the efficacy of anti-PD-1, thus suggesting that other strain(s) of gut microbiota in SPF mice may impact this and need to be investigated.Citation Format: Tao Yang, Bonnie Xiaobo Chen, Rongfei Lu, Xiaoyu An, Mingfa Zang, Jingjun Li, Sheng Guo, Wubin Qian, Jian Fei, Tongyang Hao, Edward Xu, Henry Li. The introduction of a single strain of Bacillus into a germ-free environment did not impact the anti-PD-1 efficacy in a MC38 syngeneic model [abstract]. In: Proceedings of the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics; 2021 Oct 7-10. Philadelphia (PA): AACR; Mol Cancer Ther 2021;20(12 Suppl):Abstract nr P103." @default.
• W4200417908 created "2021-12-31" @default.
• W4200417908 creator A5013283605 @default.
• W4200417908 creator A5014045056 @default.
• W4200417908 creator A5016139817 @default.
• W4200417908 creator A5032815142 @default.
• W4200417908 creator A5034458392 @default.
• W4200417908 creator A5037174499 @default.
• W4200417908 creator A5037546003 @default.
• W4200417908 creator A5060819884 @default.
• W4200417908 creator A5062659458 @default.
• W4200417908 creator A5070455766 @default.
• W4200417908 creator A5083900467 @default.
• W4200417908 creator A5090810402 @default.
• W4200417908 date "2021-12-01" @default.
• W4200417908 modified "2023-10-17" @default.
• W4200417908 title "Abstract P103: The introduction of a single strain of Bacillus into a germ-free environment did not impact the anti-PD-1 efficacy in a MC38 syngeneic model" @default.
• W4200417908 doi "https://doi.org/10.1158/1535-7163.targ-21-p103" @default.
• W4200417908 hasPublicationYear "2021" @default.
• W4200417908 type Work @default.
• W4200417908 citedByCount "0" @default.
• W4200417908 crossrefType "proceedings-article" @default.
• W4200417908 hasAuthorship W4200417908A5013283605 @default.
• W4200417908 hasAuthorship W4200417908A5014045056 @default.
• W4200417908 hasAuthorship W4200417908A5016139817 @default.
• W4200417908 hasAuthorship W4200417908A5032815142 @default.
• W4200417908 hasAuthorship W4200417908A5034458392 @default.
• W4200417908 hasAuthorship W4200417908A5037174499 @default.
• W4200417908 hasAuthorship W4200417908A5037546003 @default.
• W4200417908 hasAuthorship W4200417908A5060819884 @default.
• W4200417908 hasAuthorship W4200417908A5062659458 @default.
• W4200417908 hasAuthorship W4200417908A5070455766 @default.
• W4200417908 hasAuthorship W4200417908A5083900467 @default.
• W4200417908 hasAuthorship W4200417908A5090810402 @default.
• W4200417908 hasConcept C121608353 @default.
• W4200417908 hasConcept C126322002 @default.
• W4200417908 hasConcept C159654299 @default.
• W4200417908 hasConcept C203014093 @default.
• W4200417908 hasConcept C2522874641 @default.
• W4200417908 hasConcept C2777701055 @default.
• W4200417908 hasConcept C2777991845 @default.
• W4200417908 hasConcept C2779600528 @default.
• W4200417908 hasConcept C502942594 @default.
• W4200417908 hasConcept C542903549 @default.
• W4200417908 hasConcept C71924100 @default.
• W4200417908 hasConcept C86803240 @default.
• W4200417908 hasConcept C8891405 @default.
• W4200417908 hasConceptScore W4200417908C121608353 @default.
• W4200417908 hasConceptScore W4200417908C126322002 @default.
• W4200417908 hasConceptScore W4200417908C159654299 @default.
• W4200417908 hasConceptScore W4200417908C203014093 @default.
• W4200417908 hasConceptScore W4200417908C2522874641 @default.
• W4200417908 hasConceptScore W4200417908C2777701055 @default.
• W4200417908 hasConceptScore W4200417908C2777991845 @default.
• W4200417908 hasConceptScore W4200417908C2779600528 @default.
• W4200417908 hasConceptScore W4200417908C502942594 @default.
• W4200417908 hasConceptScore W4200417908C542903549 @default.
• W4200417908 hasConceptScore W4200417908C71924100 @default.
• W4200417908 hasConceptScore W4200417908C86803240 @default.
• W4200417908 hasConceptScore W4200417908C8891405 @default.
• W4200417908 hasLocation W42004179081 @default.
• W4200417908 hasOpenAccess W4200417908 @default.
• W4200417908 hasPrimaryLocation W42004179081 @default.
• W4200417908 hasRelatedWork W1737277 @default.
• W4200417908 hasRelatedWork W2353310 @default.
• W4200417908 hasRelatedWork W2721165 @default.
• W4200417908 hasRelatedWork W3217389 @default.
• W4200417908 hasRelatedWork W4358712 @default.
• W4200417908 hasRelatedWork W5099582 @default.
• W4200417908 hasRelatedWork W7233997 @default.
• W4200417908 hasRelatedWork W7323861 @default.
• W4200417908 hasRelatedWork W8058811 @default.
• W4200417908 hasRelatedWork W8585443 @default.
• W4200417908 isParatext "false" @default.
• W4200417908 isRetracted "false" @default.
• W4200417908 workType "article" @default.